Pharmaceutical R&D Strategies Innovation & Productivity Rationale

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research analyzes the challenges in pharmaceutical R&D. The strategies and R&D pipeline of top 10 pharmaceutical companies has been analyzed.

Table of Contents

Pharmaceutical R&D Strategies– Innovation & Productivity Rationale, Executive Summary An Overview Pharmaceutical R&D StrategiesPharmaceutical R&D Strategies– Innovation & Productivity Rationale, IntroductionMarket Overview OverviewPharmaceutical R&D Strategies– Innovation & Productivity Rationale, R&D InformaticsHarmonization of IT and R&DChallenges in R&D ProductivityApplications in Pharmaceutical IndustryApplicationsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, PfizerResearch and Development ChallengesPfizer - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development Pipeline Pipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Glaxo SmithKlineResearch and Development ChallengesGlaxo SmithKline (GSK) - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Sanofi-AventisResearch and Development ChallengesSanofi-Aventis OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Johnson & JohnsonResearch and Development ChallengesJohnson & Johnson OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Merck & Co.Research and Development ChallengesMerck & Co. OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Astra ZenecaResearch and Development ChallengesAstra Zeneca - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, NovartisResearch and Development ChallengesNovartis - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Bristol-Myers SquibbResearch and Development ChallengesBristol Myers Squibb - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, RocheResearch and Development ChallengesRoche - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Eli LillyResearch and Development ChallengesEli Lilly - OverviewCurrent ScenarioTrends and OpportunitiesResearch and DevelopmentAlliancesResearch and Development PipelinePipeline DrugsPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Frost & Sullivan AwardsFrost & Sullivan Awards Frost & Sullivan Awards for the Pharmaceutical MarketProduct Differentiation Innovation AwardProduct Innovation AwardProduct Line Strategy Leadership AwardPharmaceutical R&D Strategies– Innovation & Productivity Rationale, Decision Support DatabasesDecision Support DatabasesPharmaceutical R&D ExpendituresPharma R&D Expenditures as Per Cent of Pharma MarketPrevalence of Alzheimers' DiseaseIncidence of Lung Cancer Prevalence of Diabetes




Related Research

Release Date : 18-Sep-17

Region : Europe

Release Date : 15-Sep-17

Region : Europe

Release Date : 08-Sep-17

Region : Europe

Release Date : 06-Sep-17

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.